4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-006804
Chief Financial Officer sold 18,322 shares at an average $80.31 ($1,471,394)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonstein Sara Chief Financial Officer | 2025-02-18 | Sale 10b5-1 | −17,622 | $80.28 | $1,414,694 | 119,563 | D: show line 1 in the form |
| Bonstein Sara Chief Financial Officer | 2025-02-18 | Sale 10b5-1 | −700 | $81.00 | $56,700 | 118,863 | D: show line 2 in the form |
| Open-market sales · 18,322 sh · avg $80.31 · $1,471,394 | |||||||
Loading xslF345X05/wk-form4_1740088339.xml…